Bristol-Myers Snatches Five-, 30-Year Coupon Records
Bristol-Myers Squibb Co. (BMY) attained the lowest-borrowing costs on record for five- and 30-year bonds Thursday as part of a $2 billion bond sale.
The global biopharmaceutical company, rated in the single-A range, sold $500 million of 30-year bonds with a 3.25% coupon--the lowest ever, according to Dealogic records going back to 1995. The prior record was 3.60%, set earlier this month by Monsanto Co. (MON).
Bristol-Myers sold $750 million of five-year bonds bearing a coupon of 0.875%, another record low. The prior record was 1%, set by 3M Co. (MMM) last month.